The impact of approved anti-obesity medications on osteoarthritis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The impact of approved anti-obesity medications on osteoarthritis

Published:2024-07-23 Issue:11 Volume:25 Page:1565-1573
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Baser Onur¹²³,Rodchenko Katarzyna⁴,Vivier Elizabeth⁴,Baser Isabel⁴,Lu Yuanqing⁴,Mohamed Munira⁴

Affiliation:

1. Department of Economics, Bogazici University, Bebek, Istanbul, Turkiye

2. Graduate School of Public Health, City University of New York, Ann Arbor, MI, USA

3. Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA

4. Department of Health Economics and Outcomes Research, Columbia Data Analytics, New York, NY, USA

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2024.2391524

Reference35 articles.

1. Obesity & osteoarthritis;King LK;Indian J Med Res,2013

2. Obesity and osteoarthritis

3. Obesity and Osteoarthritis: Disease Genesis and Nonpharmacologic Weight Management

4. Musculoskeletal Pain, Fear Avoidance Behaviors, and Functional Decline in Obesity

5. The Weight-loss Effect of GLP-1RAs Glucagon-Like Peptide-1 Receptor Agonists in Non-diabetic Individuals with Overweight or Obesity: A Systematic Review with Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP